accesso Technology (ACSO LN) First healthcare partnership | Clinigen Group (CLIN LN) Downgrades irritating, mask more important progress | IDOX (IDOX LN) First steps to rebuilding confidence | IndigoVision Group (IND LN) Period of stabilisation targeted | Maistro (MAIS LN) Much improved H2’17 performance | Nichols (NICL LN) Finals highlight another year of excellent top-line execution | Redde (REDD LN) Growth from new relationship, 3-8% EPS upgrades
01 Mar 2018
Morning Song
accesso Technology Group Plc (ACSO:LON), 534 | Idox plc (IDOX:LON), 62.1 | Idox plc (IDOX:LON), 62.1 | Indigovision Group (IND:LON), 0 | Maistro (MAIS:LON), 0 | Nichols plc (NICL:LON), 990 | Redde Northgate PLC (21W:FRA), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
accesso Technology Group Plc (ACSO:LON), 534 | Idox plc (IDOX:LON), 62.1 | Idox plc (IDOX:LON), 62.1 | Indigovision Group (IND:LON), 0 | Maistro (MAIS:LON), 0 | Nichols plc (NICL:LON), 990 | Redde Northgate PLC (21W:FRA), 0
- Published:
01 Mar 2018 -
Author:
N+1 Singer Team -
Pages:
15
accesso Technology (ACSO LN) First healthcare partnership | Clinigen Group (CLIN LN) Downgrades irritating, mask more important progress | IDOX (IDOX LN) First steps to rebuilding confidence | IndigoVision Group (IND LN) Period of stabilisation targeted | Maistro (MAIS LN) Much improved H2’17 performance | Nichols (NICL LN) Finals highlight another year of excellent top-line execution | Redde (REDD LN) Growth from new relationship, 3-8% EPS upgrades